Loading...
The mould war: developing an armamentarium against fungal pathogens utilising thymoquinone, ocimene, and miramistin within bacterial cellulose matrices
Swingler, Sam ; Gupta, Abishek ; Gibson, Hazel ; Heaselgrave, Wayne ; ; Adamus, Grazyna ; Radecka, Izabela
Swingler, Sam
Gupta, Abishek
Gibson, Hazel
Heaselgrave, Wayne
Adamus, Grazyna
Radecka, Izabela
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2021-05-18
Submitted date
Alternative
Abstract
An increase in antifungal resistance has seen a surge in fungal wound infections in patients who are immunocompromised resulting from chemotherapy, disease, and burns. Human pathogenic fungi are increasingly becoming resistant to a sparse repertoire of existing antifungal drugs, which has given rise to the need to develop novel treatments for potentially lethal infections. Bacterial cellulose (BC) produced by Gluconacetobacter xylinus has been shown to possess many properties that make it innately useful as a next-generation biopolymer to be utilised as a wound dressing. The current study demonstrates the creation of a pharmacologically active wound dressing by loading antifungal agents into a biopolymer hydrogel to produce a novel wound dressing. Amphotericin B is known to be highly hepatotoxic, which reduces its appeal as an antifungal drug, especially in patients who are immunocompromised. This, coupled with an increase in antifungal resistance, has seen a surge in fungal wound infections in patients who are immunodeficient due to chemotherapy, disease, or injury. Antifungal activity was conducted via Clinical & Laboratory Standards Institute (CLSI) M27, M38, M44, and M51 against Candida auris, Candida albicans, Aspergillus fumigatus, and Aspergillus niger. This study showed that thymoquinone has a comparable antifungal activity to amphotericin B with mean zones of inhibition of 21.425 ± 0.925 mm and 22.53 ± 0.969 mm, respectively. However, the mean survival rate of HEp-2 cells when treated with 50 mg/L amphotericin B was 29.25 ± 0.854% compared to 71.25 ± 1.797% when treated with 50 mg/L thymoquinone. Following cytotoxicity assays against HEp-2 cells, thymoquinone showed a 71.25 ± 3.594% cell survival, whereas amphotericin B had a mean cell survival rate of 29.25 ± 1.708%. The purpose of this study was to compare the efficacy of thymoquinone, ocimene, and miramistin against amphotericin B in the application of novel antifungal dressings.
Citation
Swingler S, Gupta A, Gibson H, Heaselgrave W, Kowalczuk M, Adamus G, Radecka I. (2021) The Mould War: Developing an Armamentarium against Fungal Pathogens Utilising Thymoquinone, Ocimene, and Miramistin within Bacterial Cellulose Matrices. Materials. 2021; 14(10):2654. https://doi.org/10.3390/ma14102654
Publisher
Journal
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
© 2021 The Authors. Published by MDPI. This is an open access article available under a Creative Commons licence.
The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.3390/ma14102654
Series/Report no.
ISSN
1996-1944
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
Partial financial support from the European Regional Development Fund Project EnTRESS No. 01R16P00718.